ReviewInternational review of cell and molecular biology2024

Unravelling the molecular basis of PARP inhibitor resistance in prostate cancer with homologous recombination repair deficiency.

Nabila Zaman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.